Laing F. Rikkers

Senior Managing Director

Ms. Rikkers is an experienced manager with a track record of building corporate infrastructures and effective organizations. As a member of the Investment Committee and an advisor to portfolio companies at HealthpointCapital, her principal role is in developing strategies within organizations. Ms. Rikkers has been at HealthpointCapital for 12 years and prior she spent 10 years in management positions at Amerada Hess Corporation, the Walt Disney Company and New York-Presbyterian Hospital focused on Organizational Development and Human Resources. Ms. Rikkers is a member of the Board of Directors at HealthpointCapital LLC, BioHorizons, Inc. and MicroDental Laboratories, Inc. She is a Cabinet member of the Salk Excellerators and a member of the Salk Institute Council at the Salk Institute for Biological Studies. Ms. Rikkers received a B.A. from Harvard College and an M.A. in Organizational Psychology from Columbia University.

Recent Articles by Laing Rikkers

In a Troubled Economy, Companies Weigh the Value of Conference Attendance MAY 12, 2009

As you might expect in times of economic uncertainty, companies are taking a hard look at their expenses and questioning what is essential and what is not. One of the areas that is under the microscope is spending on conference... more

Straumann's Strategic Moves Play Out MAR 6, 2007

Straumann, the second largest dental implant company, has been on our radar a few times this month. First, Straumann is getting press for stating its interest in buying the not-yet-for-sale Biomet 3i. 3i would give it needed scale and management... more

Physician Income Cut AUG 11, 2006

This week CMS proposed a 5.1% reduction in payments to physicians for 2007. The proposal will impact the 875,000 doctors who care for the elderly and disabled in the US. The explanation for the cut is that spending on physician... more

A Voice for Innovation: MDMA JUN 16, 2006

On June 14th and 15th, we attended the Medical Device Manufacturers Association (MDMA) Annual Meeting. The organization provides medical device entrepreneurs an opportunity to have their voices heard on the hill. Innovation in our industry generally comes from the smaller... more

Class III Continues for Bone Growth Stimulation JUN 9, 2006

On Friday, June 2, the FDA's Orthopedic and Rehabilitation Devices Panel met to discuss the RS Medical petition to reclassify noninvasive bone growth stimulators from Class III to Class II. In a 4-2 vote, the panel recommended leaving the bone... more